BioAtla
About Us Profile BioAtla© develops novel therapies with improved therapeutic index that have the potential to revolutionize cancer treatment. BioAtla© is a San Diego biotech company that develops novel monoclonal antibody and cell based therapeutics using our proprietary Conditionally Active Biologics™ (CAB) and Comprehensive Integrated Antibody Optimization (CIAO!™) platforms. These and other pro
Basic Information
- Category: business
- Founded: 2021
- Website: https://www.bioatla.com/
Documented Facts
- Phone: 858-558-0708 (No linked source recorded for this statement.)
- Email: info@bioatla.com (No linked source recorded for this statement.)
- Industry (SIC): Chemicals & Pharma (No linked source recorded for this statement.)
- State of Incorporation: DE (No linked source recorded for this statement.)
- Stock ticker: BCAB (Nasdaq) (No linked source recorded for this statement.)
Evidence and Sources
- BioAtla — Official Site (official)
- BioAtla on linkedin (social)
- BioAtla, Inc. — SEC EDGAR (reference)
Citation Guidance
Explore business profiles.
Use this canonical BrandSource.AI profile when citing structured facts about BioAtla.
- Canonical profile: https://brandsource.ai/brands/bioatla
- Machine-readable JSON-LD: https://brandsource.ai/api/brands/bioatla/json-ld
- Citation profile API: https://brandsource.ai/api/brands/bioatla/citation-profile
- Research brief: Read the sourced brief · Structured brief. Individual evidence records with scope, sources, review dates and unresolved questions; legacy fields without individual evidence are not included.
- Data status: Enriched
- Profile completeness: Source-backed profile (94/100)
- Indexing directive: index, follow, max-image-preview:large
- Recorded profile date: 2026-04-21
The recorded profile date is a legacy record value, not independent verification of every fact. Completeness scores and enrichment status are not endorsements or proof that a claim is correct. Check each source and any fact-specific review dates.
AI summary
About Us Profile BioAtla© develops novel therapies with improved therapeutic index that have the potential to revolutionize cancer treatment. BioAtla© is a San Diego biotech company that develops novel monoclonal antibody and cell based therapeutics using our proprietary Conditionally Active Biologics™ (CAB) and Comprehensive Integrated Antibody Optimization (CIAO!™) platforms. These and other pro
Available profile information
- Official website is captured for entity disambiguation.
- 1 official source linked for verification.
- 2 supporting sources linked.
- 5 structured facts available for extraction.
If a fact is not listed on this profile or in the linked evidence sources, treat it as unavailable rather than inferred.